Compare Twist Bioscience Corp (TWST) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Twist Bioscience Corp vs Verizon Communications Inc — how do they compare? Twist Bioscience Corp trades at $159.78 (market cap $10.08B), while Verizon Communications Inc trades at $41.65 (market cap $192.57B). The key difference: Verizon Communications Inc is far larger — about 19.1× Twist Bioscience Corp's market cap, and Verizon Communications Inc pays a 6.11% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Twist Bioscience Corp for 27 Days and Verizon Communications Inc for 109 Days on average.
| TWST | VZ | |
|---|---|---|
Market Cap | $10.08B | $192.57B |
Volume | 4,229,037 | 20,940,094 |
Sector | Health | Media |
52-Week High | $205.00 | $51.45 |
52-Week Low | $25.45 | $38.40 |
Typical Hold Time | 27 Days | 109 Days |
Enterprise Value | $10.01B | $379.28B |
Dividend Yield | — | 6.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Twist Bioscience (TWST) trades at $159.78, up 2.65% today, showing strong momentum despite mixed technical signals. The company continues to demonstrate robust revenue growth, with 2025 revenue reaching $377 million, though profitability remains elusive with a -31.66% net income margin. Recent positive developments include a strategic partnership with Eli Lilly's TuneLab AI platform announced September 16, 2026, driving investor optimism about the company's AI-driven drug discovery capabilities.
While analyst consensus remains bullish with 73% buy ratings, the stock faces significant fundamental challenges including persistent cash burn and negative earnings. The current price exceeds the $145.20 consensus target, suggesting limited near-term upside. Key risks include execution challenges in achieving profitability and dependence on AI partnerships for growth catalysts.
Verizon (VZ) trades at $46.35, up 1.27% today, with a bearish technical signal but strong fundamentals including a P/E of 12.07 and net income margin of 11.64%. Recent earnings beats and a $0.71 dividend highlight stability, while cash flow improved to $14.86B in 2025. The stock is near its consensus price target of $48.17, with analyst sentiment mixed but leaning hold.
Outlook: Verizon offers value with steady dividends and cash flow, but faces competition and debt risks. Upside depends on execution in wireless markets; cautious optimism is warranted given technical weakness and modest growth projections.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
